iRadimed Corp 2024年度报告

(Exact Name of Registrant As Specified In Its Charter) SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:None. Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☐No☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements forthe past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit suchfiles). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” inRule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☒Emerging growth company☐ Large accelerated filer☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new orrevised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal controlover financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its auditreport.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in thefiling reflect the correction of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation receivedby any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes☐No☒ As of June 30, 2024, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of its shares held bynon-affiliates was approximately $349,253,009. DOCUMENTS INCORPORATED BY REFERENCE The information that is required to be included in Part III of this Annual Report on Form 10-K is incorporated by reference from the registrant’s definitiveproxy statement for the 2025 Annual Meeting of Stockholders to be filed by the registrant within 120 days of December 31, 2024. Only those portions of any suchdefinitive proxy statement that are specifically incorporated by reference herein shall constitute a part of this Annual Report on Form 10-K. TABLE OF CONTENTS IRADIMED CORPORATION.TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-KFor the Fiscal Year Ended December 31, 2024 PART I1ITEM1.BUSINESS1ITEM1A.RISK FACTORS20ITEM1B.UNRESOLVED STAFF COMMENTS38ITEM 1C.CYBERSECURITY38ITEM2.PROPERTIES39ITEM3.LEGAL PROCEEDINGS39ITEM4.MINE SAFETY DISCLOSURES39PART II40ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDERMATTERSAND ISSUER PURCHASES OF EQUITY SECURITIES40ITEM6.[RESERVED]41ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ANDRESULTS OF OPERATIONS42ITEM7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK48ITEM8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA48ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING ANDFINANCIAL DISCLOSURE48ITEM9A.CONTROLS AND PROCEDURES49ITEM9B.OTHER INFORMATION50ITEM 9C.DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS50PART III50ITEM10.DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE50ITEM11.EXECUTIVE COMPENSATION50ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENTANDRELATED STOCKHOLDER MATTERS50ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTORINDEPENDENCE50ITEM14.PRINCIPAL ACCOUNTANT FEES AND SERVICES50PART IV51ITEM15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES51ITEM16.FORM10-K SUMMARY51EXHIBITINDEX51SIGNATURES53INDEX TO FINANCIAL STATEMENTSF-1 CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K (this “Form 10-K” or “Annual Report”) within the meaning under Section27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of1934, as amended (the “Exchange Act”). Forward-looking stat